TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency

Laboratory Investigation

Volumn 95, Issue 2, 2015, Pages 223-236

  Fernández Álvarez, Sara ^a   Gutiérrez De Juan, Virginia ^a   Zubiete Franco, Imanol ^a   Barbier Torres, Lucia ^a   Lahoz, Agustín ^b   Parés, Albert ^c   Luka, Zigmund ^d   Wagner, Conrad ^d   Lu, Shelly C ^e   Mato, José M ^a   Martínez Chantar, Mariá L ^a,f   Beraza, Naiara ^a,g  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^g BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE METHYLTRANSFERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TNFSF10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; DISEASE COURSE; ENZYME DEFICIENCY; ENZYME INHIBITION; FIBROGENESIS; GENE SILENCING; HUMAN; HUMAN TISSUE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BILE DUCT; DEFICIENCY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; END STAGE LIVER DISEASE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LIGATION; METABOLISM; PATHOLOGY; SURGERY; WESTERN BLOTTING;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BILE DUCTS; BLOTTING, WESTERN; END STAGE LIVER DISEASE; FLOW CYTOMETRY; GLYCINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LIGATION; MICE; MICE, KNOCKOUT; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84921834042     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.151     Document Type: Article

References (30)

1. Martinez-Lopez N, Varela-Rey M, Ariz U, et al. S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans 2008;36:848-852.
2. Avila MA, Berasain C, Torres L, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000;33:907-914.
3. Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008;47:1191-1199.
4. Gomez-Santos L, Luka Z, Wagner C, et al. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase. Hepatology 2012;56:747-759.
5. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
6. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004;39:273-278.
7. Watanabe A, Hashmi A, Gomes DA, et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 2007;46:1509-1518.
8. Syn WK, Agboola KM, Swiderska M, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 2012;61:1323-1329.
9. Radaeva S, Wang L, Radaev S, et al. Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol 2007;293:G809-G816.
10. Radaeva S, Sun R, Jaruga B, et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006;130:435-452.
11. Shimoda S, Harada K, Niiro H, et al. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology 2011;53:1270-1281.
12. Chuang YH, Lian ZX, Tsuneyama K, et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 2006;26:232-240.
13. Takeda K, Kojima Y, Ikejima K, et al. Death receptor 5 mediatedapoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci USA 2008;105:10895-10900.
14. Kahraman A, Barreyro FJ, Bronk SF, et al. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 2008;47:1317-1330.
15. Kahraman A, Schlattjan M, Kocabayoglu P, et al. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 2010;51:92-102.
16. Luka Z, Capdevila A, Mato JM, et al. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res 2006;15:393-397.
17. Fickert P, Zollner G, Fuchsbichler A, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251.
18. Beraza N, Ludde T, Assmus U, et al. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007;132:2504-2517.
19. Beraza N, Malato Y, Sander LE, et al. Hepatocyte-specific NEMO deletion promotes NK/NKT cell-and TRAIL-dependent liver damage. J Exp Med 2009;206:1727-1737.
20. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332.
21. Seki E, De Minicis S, Gwak GY, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 2009;119:1858-1870.
22. Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gammadependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193:661-670.
23. Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001;7: 94-100.
24. Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-752.
25. Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013;1832:1061-1069.
26. Jiang JX, Mikami K, Venugopal S, et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 2009;51: 139-148.
27. Liedtke C, Bangen JM, Freimuth J, et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011;141:2176-2187.
28. Galluzzi L, Kepp O, Kroemer G. FADD: an endogenous inhibitor of RIP3-driven regulated necrosis. Cell Res 2011;21:1383-1385.
29. Mehal W, Imaeda A. Cell death and fibrogenesis. Semin. Liver Dis 2010;30:226-231.
30. Shetty S, Gladden JB, Henson ES, et al. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Apoptosis 2002;7:413-420.